These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 26264858)

  • 1. Reserve-building activities in multiple sclerosis patients and healthy controls: a descriptive study.
    Schwartz CE; Ayandeh A; Ramanathan M; Benedict R; Dwyer MG; Weinstock-Guttman B; Zivadinov R
    BMC Neurol; 2015 Aug; 15():135. PubMed ID: 26264858
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reserve-related activities and MRI metrics in multiple sclerosis patients and healthy controls: an observational study.
    Schwartz CE; Dwyer MG; Benedict R; Weinstock-Guttman B; Bergsland NP; Li J; Ramanathan M; Zivadinov R
    BMC Neurol; 2016 Jul; 16():108. PubMed ID: 27430316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive reserve and symptom experience in multiple sclerosis: a buffer to disability progression over time?
    Schwartz CE; Quaranto BR; Healy BC; Benedict RH; Vollmer TL
    Arch Phys Med Rehabil; 2013 Oct; 94(10):1971-81. PubMed ID: 23727344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis.
    Sato S; Lim J; Miehm JD; Buonaccorsi J; Rajala C; Khalighinejad F; Ionete C; Kent JA; van Emmerik REA
    Mult Scler Relat Disord; 2020 Jun; 41():102031. PubMed ID: 32172213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cervical cord area is associated with infratentorial grey and white matter volume predominantly in relapsing-remitting multiple sclerosis: A study using semi-automated cord volumetry and voxel-based morphometry.
    Bellenberg B; Schneider R; Weiler F; Suchan B; Haghikia A; Hoffjan S; Gold R; Köster O; Lukas C
    Mult Scler Relat Disord; 2015 May; 4(3):264-72. PubMed ID: 26008944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. IL17 and IFNgamma production by peripheral blood mononuclear cells from clinically isolated syndrome to secondary progressive multiple sclerosis.
    Frisullo G; Nociti V; Iorio R; Patanella AK; Marti A; Caggiula M; Mirabella M; Tonali PA; Batocchi AP
    Cytokine; 2008 Oct; 44(1):22-5. PubMed ID: 18793860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and diagnosis of Secondary Progressive Multiple Sclerosis during the clinical encounter: Results from a physician survey.
    Alvarez E; Nair KV; Gorritz M; Bartolome L; Maloney H; Ding Y; Golan T; Wade RL; Kumar R; Su W; Shah R; Russo P
    Mult Scler Relat Disord; 2021 May; 50():102858. PubMed ID: 33799068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of anxiety symptoms and correlates of anxiety in people with progressive and relapsing-remitting multiple sclerosis.
    Knowles LM; Tingey JL; Newman AK; von Geldern G; Alschuler KN
    Mult Scler Relat Disord; 2022 Jul; 63():103918. PubMed ID: 35700673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Limb apraxia in multiple sclerosis: prevalence and impact on manual dexterity and activities of daily living.
    Kamm CP; Heldner MR; Vanbellingen T; Mattle HP; Müri R; Bohlhalter S
    Arch Phys Med Rehabil; 2012 Jun; 93(6):1081-5. PubMed ID: 22464095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping face encoding using functional MRI in multiple sclerosis across disease phenotypes.
    Rocca MA; Vacchi L; Rodegher M; Meani A; Martinelli V; Possa F; Comi G; Falini A; Filippi M
    Brain Imaging Behav; 2017 Oct; 11(5):1238-1247. PubMed ID: 27714550
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H; Schneider T; Yiannakas MC; Altmann DR; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How effective are disease-modifying drugs in delaying progression in relapsing-onset MS?
    Brown MG; Kirby S; Skedgel C; Fisk JD; Murray TJ; Bhan V; Sketris IS
    Neurology; 2007 Oct; 69(15):1498-507. PubMed ID: 17699802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Persons with secondary progressive and relapsing remitting multiple sclerosis reveal different responses of tryptophan metabolism to acute endurance exercise and training.
    Bansi J; Koliamitra C; Bloch W; Joisten N; Schenk A; Watson M; Kool J; Langdon D; Dalgas U; Kesselring J; Zimmer P
    J Neuroimmunol; 2018 Jan; 314():101-105. PubMed ID: 29224960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Corneal Immune Cells Are Increased in Patients With Multiple Sclerosis.
    Khan A; Li Y; Ponirakis G; Akhtar N; Gad H; George P; Ibrahim FM; Petropoulos IN; Canibano BG; Deleu D; Shuaib A; Kamran S; Malik RA
    Transl Vis Sci Technol; 2021 Apr; 10(4):19. PubMed ID: 34003997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination of CSF N-acetylaspartate and neurofilaments in multiple sclerosis.
    Teunissen CE; Iacobaeus E; Khademi M; Brundin L; Norgren N; Koel-Simmelink MJ; Schepens M; Bouwman F; Twaalfhoven HA; Blom HJ; Jakobs C; Dijkstra CD
    Neurology; 2009 Apr; 72(15):1322-9. PubMed ID: 19365053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML; Xu EH; Dong HQ; Zhang JW
    Zhonghua Yi Xue Za Zhi; 2016 Apr; 96(15):1173-7. PubMed ID: 27117362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term influence of combined oral contraceptive use on the clinical course of relapsing-remitting multiple sclerosis.
    Gava G; Bartolomei I; Costantino A; Berra M; Venturoli S; Salvi F; Meriggiola MC
    Fertil Steril; 2014 Jul; 102(1):116-22. PubMed ID: 24794311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking as a risk factor for development of Secondary Progressive Multiple Sclerosis: A study in IRAN, Guilan.
    Roudbari SA; Ansar MM; Yousefzad A
    J Neurol Sci; 2013 Jul; 330(1-2):52-5. PubMed ID: 23628463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting the severity of relapsing-remitting MS: the contribution of cross-sectional and short-term follow-up MRI data.
    Enzinger C; Fuchs S; Pichler A; Wallner-Blazek M; Khalil M; Langkammer C; Ropele S; Fazekas F
    Mult Scler; 2011 Jun; 17(6):695-701. PubMed ID: 21228028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.